Sign Up Now to Download a Free Research Report on AEGR

Sign-Up to Get the Equity Report on this Company Plus Exclusive Access to Our Winning Newsletter Alerts





Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader.

Aegerion Pharmaceuticals, Inc.

Aegerion Pharmaceuticals shares spiked 14.06 percent on volume of 2.18 million shares traded Wednesday to close at $69.28. JPMorgan currently has an “overweight” rating on the company and has recently raised its price target to $69.00 from $48.00. Shares of Aegerion Pharmaceuticals have gained over 170 percent year-to-date.

Going forward ... (see research report)



RESEARCH REPORT ON AEGR Download Free Report Now


Preview Pages of Actual Equity Report

Download Adobe Reader Having problems viewing PDF files? Download Adobe Reader. Research Report on    Research Report on    Research Report on    

Research Report on    Research Report on    Research Report on